A sudden regulatory shift threatens to dismantle the outsourced remote patient monitoring industry overnight.

Medicare just threw a massive wrench into the digital health machine. In its proposed 2027 physician fee schedule, the agency wants to ban third-party vendors from delivering remote patient monitoring services on behalf of doctors. If finalized, only clinical staff directly employed by the billing practice can perform these services.

The Fraud Crackdown

For years, remote monitoring was a digital health gold rush. Startups pitched turnkey solutions to doctors, promising passive revenue while the vendors handled the actual patient tracking. But federal watchdogs recently flagged widespread fraud, waste, and abuse in the sector. This proposal is Medicare’s blunt-force instrument to clean up the market.

It is a classic regulatory overcorrection.

By targeting bad actors, the policy threatens to take down legitimate care models. Most independent clinics simply do not have the budget or headcount to hire full-time, in-house clinical staff just to monitor data feeds.

The Industry Fallout

If doctors cannot outsource the labor, many will simply abandon remote monitoring entirely. This risks cutting off patients from vital, continuous care tools that keep them out of hospitals.

The proposal also introduces friction by requiring an initiating face-to-face visit and lowering device valuations. It signals a broader skepticism toward virtual-first care models that rely on automated scale rather than localized doctor-patient relationships. For digital health startups, the implications are existential. Companies built entirely on outsourced monitoring must now completely rewrite their business models or face extinction.